JANX
Janux Therapeutics·NASDAQ
--
--(--)
--
--(--)
JANX fundamentals
Janux Therapeutics (JANX) released its earnings on Aug 7, 2025: revenue was 0 (YoY -100.00%), missed estimates; EPS was -0.55 (YoY -400.00%), missed estimates.
Revenue / YoY
0
-100.00%
EPS / YoY
-0.55
-400.00%
Report date
Aug 7, 2025
EPS
Actual | -0.62 | -0.26 | -0.33 | -0.32 | -0.41 | -0.4 | -0.39 | -0.42 | -0.42 | -0.25 | -0.25 | -0.3 | -0.11 | -0.51 | -0.36 | -0.38 | -0.55 |
Forecast | -0.14 | -0.1767 | -0.27 | -0.32 | -0.3167 | -0.4675 | -0.4812 | -0.486 | -0.502 | -0.47 | -0.4152 | -0.3313 | -0.3107 | -0.3273 | -0.4607 | -0.3821 | -0.4723 |
Surprise | -342.86% | -47.14% | -22.22% | 0.00% | -29.46% | +14.44% | +18.95% | +13.58% | +16.33% | +46.81% | +39.79% | +9.45% | +64.60% | -55.82% | +21.86% | +0.55% | -16.45% |
Revenue
Actual | 491.00K | 1.16M | 1.62M | 1.59M | 2.38M | 1.81M | 2.85M | 2.05M | 1.06M | 2.52M | 2.46M | 1.25M | 8.90M | 439.00K | 0 | 0 | 0 |
Forecast | 133.33K | 133.33K | 433.33K | 810.40K | 650.00K | 742.58K | 805.50K | 672.35K | 875.00K | 845.50K | 750.00K | 878.57K | 772.00K | 1.50M | 409.92K | 590.91K | 272.73K |
Surprise | +268.25% | +769.25% | +272.92% | +96.75% | +266.54% | +144.15% | +253.20% | +204.60% | +20.80% | +197.69% | +228.13% | +42.50% | +1052.46% | -70.64% | -100.00% | -100.00% | -100.00% |
Earnings Call
You can ask Aime
What is Janux Therapeutics's latest dividend and current dividend yield?What were the key takeaways from Janux Therapeutics's earnings call?What does Janux Therapeutics do and what are its main business segments?What factors drove the changes in Janux Therapeutics's revenue and profit?What is Janux Therapeutics's gross profit margin?What guidance did Janux Therapeutics's management provide for the next earnings period?Did Janux Therapeutics beat or miss consensus estimates last quarter?What were the key takeaways from Janux Therapeutics’s earnings call?
